PodPitch
PodcastsRank #12086
Artwork for The Bio Report

The Bio Report

Levine Media Group
Share:
Life SciencesPodcastsScienceBusinessENunited-statesDaily or near-daily
3.7 / 5
The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy.
Top 24.2% by pitch volume (Rank #12086 of 50,000)Data updated Feb 10, 2026

Key Facts

Publishes
Daily or near-daily
Episodes
601
Founded
N/A
Category
Life Sciences
Number of listeners
Private
Hidden on public pages

Listen to this Podcast

AppleSpotify
EpisodesMetricsListenersContactsSimilarFAQs
PreviousZen CommuterRank #12085NextThe Bulletin with UBSRank #12087
Pitch this podcast
Get the guest pitch kit.
Book a quick demo to unlock the outreach details you actually need before you hit send.
  • Verified contact + outreach fields
  • Exact listener estimates (not just bands)
  • Reply rate + response timing signals
10 minutes. Friendly walkthrough. No pressure.
Book a demo
Public snapshot
Audience: N/A
Canonical: https://podpitch.com/podcasts/the-bio-report
Cadence: Active weekly
Reply rate: 5–10%

Latest Episodes

Back to top

Reprogramming T Cells to Cross the Brain’s Border

Wed Feb 04 2026

Listen

One of the challenges of treating brain tumors is delivering potent biologic therapies across the blood-brain barrier. Adaptin Bio has developed platform technology that harnesses a patient’s own T cells to transport bispecific therapeutic payloads across the blood-brain barrier and into other targeted tissue with an initial focus on treating glioblastoma. We spoke to Michael Roberts, co-founder and CEO of Adaptin Bio, about the unmet need in glioblastoma, the limitations of current blood-brain barrier–crossing strategies, and how the company’s platform seeks to change the treatment paradigm by using patient-derived T cells as delivery vehicles for targeted biologics.

More

One of the challenges of treating brain tumors is delivering potent biologic therapies across the blood-brain barrier. Adaptin Bio has developed platform technology that harnesses a patient’s own T cells to transport bispecific therapeutic payloads across the blood-brain barrier and into other targeted tissue with an initial focus on treating glioblastoma. We spoke to Michael Roberts, co-founder and CEO of Adaptin Bio, about the unmet need in glioblastoma, the limitations of current blood-brain barrier–crossing strategies, and how the company’s platform seeks to change the treatment paradigm by using patient-derived T cells as delivery vehicles for targeted biologics.

Key Metrics

Back to top
Pitches sent
27
From PodPitch users
Rank
#12086
Top 24.2% by pitch volume (Rank #12086 of 50,000)
Average rating
3.7
Ratings count may be unavailable
Reviews
8
Written reviews (when available)
Publish cadence
Daily or near-daily
Active weekly
Episode count
601
Data updated
Feb 10, 2026
Social followers
92

Public Snapshot

Back to top
Life SciencesPodcastsScienceBusiness
Country
United States
Language
English
Language (ISO)
Release cadence
Daily or near-daily
Latest episode date
Wed Feb 04 2026

Audience & Outreach (Public)

Back to top
Audience range
Private
Hidden on public pages
Reply rate band
5–10%
Public band
Response time band
2–4 weeks
Public band
Replies received
21–50
Public band

Public ranges are rounded for privacy. Unlock the full report for exact values.

Presence & Signals

Back to top
Social followers
92
Contact available
Yes
Masked on public pages
Sponsors detected
Private
Hidden on public pages
Guest format
Private
Hidden on public pages

Social links

No public profiles listed.

Demo to Unlock Full Outreach Intelligence

We publicly share enough context for discovery. For actionable outreach data, unlock the private blocks below.

Audience & Growth
Demo to unlock
Monthly listeners49,360
Reply rate18.2%
Avg response4.1 days
See audience size and growth. Demo to unlock.
Contact preview
d***@hidden
Get verified host contact details. Demo to unlock.
Sponsor signals
Demo to unlock
Sponsor mentionsLikely
Ad-read historyAvailable
View sponsorship signals and ad read history. Demo to unlock.
Book a demo

How To Pitch The Bio Report

Back to top

Want to get booked on podcasts like this?

Become the guest your future customers already trust.

PodPitch helps you find shows, draft personalized pitches, and hit send faster. We share enough public context for discovery; for actionable outreach data, unlock the private blocks.

  • Identify shows that match your audience and offer.
  • Write pitches in your voice (nothing sends without you).
  • Move from “maybe later” to booked interviews faster.
  • Unlock deeper outreach intelligence with a quick demo.

This show is Rank #12086 by pitch volume, with 27 pitches sent by PodPitch users.

Book a demoBrowse more shows10 minutes. Friendly walkthrough. No pressure.

Reviews

Back to top
3.7 / 5
RatingsN/A
Written reviews8

We summarize public review counts here; full review text aggregation is not shown on PodPitch yet.

Frequently Asked Questions About The Bio Report

Back to top

What is The Bio Report about?

The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy.

How often does The Bio Report publish new episodes?

Daily or near-daily

How many listeners does The Bio Report get?

PodPitch shows a public audience band (like "N/A"). Book a demo to unlock exact audience estimates and how we calculate them.

How can I pitch The Bio Report?

Use PodPitch to access verified outreach details and pitch recommendations for The Bio Report. Start at https://podpitch.com/try/1.

Which podcasts are similar to The Bio Report?

This page includes internal links to similar podcasts. You can also browse the full directory at https://podpitch.com/podcasts.

How do I contact The Bio Report?

Public pages only show a masked contact preview. Book a demo to unlock verified email and outreach fields.

Quick favor for your future self: want podcast bookings without the extra mental load? PodPitch helps you find shows, draft personalized pitches, and hit send faster.

Book a demoBrowse more shows